Top

Published in:

01-06-2018 | Original Article

Breast cancer survivor’s perspectives on the role different providers play in follow-up care

Authors: J. L. Tucholka, N. Jacobson, N. M. Steffens, J. R. Schumacher, A. J. Tevaarwerk, B. Anderson, L. G. Wilke, C. C. Greenberg, Heather B. Neuman

Published in: Supportive Care in Cancer | Issue 6/2018

Abstract

Importance

Significant variation in the number and types of oncologists that provide breast cancer follow-up exists. However, there is limited understanding regarding breast cancer survivors’ preferences for who provides their follow-up. Our objective was to explore breast cancer survivors’ perspectives on the goals of breast cancer follow-up, the preferred role for primary care providers, and the perceived roles of different types of oncologists during follow-up.

Methods

A convenience sample of stage 0–III breast cancer survivors was identified and in-depth one-on-one interviews conducted. Data were analyzed using inductive content analysis.

Results

Survivors cited a strong preference for oncology-based follow-up within the first 5 years after diagnosis, driven by their need for reassurance that cancer had not recurred. Survivors also thought that their primary care provider needed to be involved. Survivors assumed that oncology follow-up was directed by a standard protocol that included streamlining the follow-up team. Survivors recognized that patients with more complex cancers or challenging treatment courses may require more intensive follow-up and deviate from the standard protocol. Most survivors were comfortable deferring decisions regarding who participated in follow-up to the oncology team.

Conclusions

Most patients think a streamlined approach to oncology-based breast cancer follow-up already occurs, driven by a standard protocol. The use of a standard protocol to provide guidance for which types of oncology providers should participate in breast cancer follow-up will streamline care and represents a significant opportunity to reduce unnecessary variation. This approach is especially critical given patients’ strong preferences for oncology-based follow-up.

Howlader N NA, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA. SEER Cancer Statistics Review, 1975–2013. Bethesda, MD.: National Cancer Institute; 2016:http://seer.cancer.gov/csr/1975_2013/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016

Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. Mar 1 2013;31(7):961–965CrossRefPubMed

National Comprehensive Cancer Network. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Breast Cancer. 2016; v.1.2016:http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. Accessed February 22, 2016

Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol: Off J Am Soc Clin Oncol 34(6):611–635CrossRef

Potosky AL, Han PK, Rowland J et al (2011) Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 26(12):1403–1410. https://doi.org/10.1007/s11606-011-1808-4 CrossRefPubMedPubMedCentral

Kantsiper M, McDonald EL, Geller G, Shockney L, Snyder C, Wolff AC (2009) Transitioning to breast cancer survivorship: perspectives of patients, cancer specialists, and primary care providers. J Gen Intern Med 24(Suppl 2):S459–S466CrossRefPubMed

Hewitt ME, Bamundo A, Day R, Harvey C (2007) Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians. J Clin Oncol 25(16):2270–2273CrossRefPubMed

Virgo KS, Lerro CC, Klabunde CN, Earle C, Ganz PA (2013) Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. J Clin Oncol 31(18):2322–2336CrossRefPubMedPubMedCentral

Klabunde CN, Han PK, Earle CC, Smith T, Ayanian JZ, Lee R, Ambs A, Rowland JH, Potosky a (2013) Physician roles in the cancer-related follow-up care of cancer survivors. Fam Med 45(7):463–474PubMedPubMedCentral

10.

Bober SL, Recklitis CJ, Campbell EG et al (2009) Caring for cancer survivors: a survey of primary care physicians. Cancer 115(18 Suppl):4409–4418CrossRefPubMed

11.

Dawes AJ, Hemmelgarn M, Nguyen DK et al (2015) Are primary care providers prepared to care for survivors of breast cancer in the safety net? Cancer 121(8):1249–1256CrossRefPubMed

12.

Margenthaler JA, Allam E, Chen L, Virgo KS, Kulkarni UM, Patel AP, Johnson FE (Mar 2012) Surveillance of patients with breast cancer after curative-intent primary treatment: current practice patterns. J Oncol Pract 8(2):79–83. https://doi.org/10.1200/JOP.2011.000289 CrossRefPubMed

13.

Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R (Jul 2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6(4):174–181. https://doi.org/10.1200/JOP.200009 CrossRefPubMedPubMedCentral

14.

Neuman HB, Weiss JM, Schrag D, Ronk K, Havlena J, LoConte NK, Smith MA, Greenberg CC (Dec 2013) Patient demographic and tumor characteristics influencing oncologist follow-up frequency in older breast cancer survivors. Ann Surg Oncol 20(13):4128–4136. https://doi.org/10.1245/s10434-013-3170-8 CrossRefPubMed

15.

Neuman HB, Rathouz PJ, Winslow E, Weiss JM, LoConte NK, Lin CP, Wurm M, Smith MA, Schrag D, Greenberg CC (Oct 2016) Use of a novel statistical technique to examine the delivery of breast cancer follow-up care by different types of oncology providers. J Eval Clin Pract 22(5):737–744. https://doi.org/10.1111/jep.12529 CrossRefPubMedPubMedCentral

16.

Ganz PA, Hahn EE, Petersen L, Melisko ME, Pierce JP, von Friederichs-Fitzwater M, Lane KT, Hiatt RA (Oct 2016) Quality of posttreatment care among breast cancer survivors in the University of California Athena Breast Health Network (Athena). Clin Breast Cancer 16(5):356–363. https://doi.org/10.1016/j.clbc.2016.05.003 CrossRefPubMedPubMedCentral

17.

Weaver KE, Aziz NM, Arora NK, Forsythe LP, Hamilton AS, Oakley-Girvan I, Keel G, Bellizzi KM, Rowland JH (Jul 2014) Follow-up care experiences and perceived quality of care among long-term survivors of breast, prostate, colorectal, and gynecologic cancers. J Oncol Practice / Am Soc Clin Oncol 10(4):e231–e239. https://doi.org/10.1200/JOP.2013.001175 CrossRef

18.

Neuman HB, Schumacher JR, Schneider DF, Winslow ER, Busch RA, Tucholka JL, Smith MA, Greenberg CC (Mar 2017) Variation in the types of providers participating in breast cancer follow-up care: a SEER-Medicare analysis. Ann Surg Oncol 24(3):683–691. https://doi.org/10.1245/s10434-016-5611-7 CrossRefPubMed

19.

Neuman HB, Steffens NM, Jacobson N, Tevaarwerk A, Anderson B, Wilke LG, Greenberg CC (Mar 2016) Oncologists’ perspectives of their roles and responsibilities during multi-disciplinary breast cancer follow-up. Ann Surg Oncol 23(3):708–714. https://doi.org/10.1245/s10434-015-4904-6 CrossRefPubMed

20.

Chewning B, Bylund CL, Shah B, Arora NK, Gueguen JA, Makoul G (Jan 2012) Patient preferences for shared decisions: a systematic review. Patient Educ Couns 86(1):9–18. https://doi.org/10.1016/j.pec.2011.02.004 CrossRefPubMed

21.

Janz NK, Wren PA, Copeland LA, Lowery JC, Goldfarb SL, Wilkins EG (2004) Patient-physician concordance: preferences, perceptions, and factors influencing the breast cancer surgical decision. J Clin Oncol 22(15):3091–3098CrossRefPubMed

22.

Katz SJ, Lantz PM, Janz NK et al (2005) Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol 23(24):5526–5533CrossRef

23.

Opatt D, Morrow M, Hawley S, Schwartz K, Janz NK, Katz SJ (Sep 2007) Conflicts in decision-making for breast cancer surgery. Ann Surg Oncol 14(9):2463–2469. https://doi.org/10.1245/s10434-007-9431-7 CrossRefPubMed

24.

Temple WJ, Russell ML, Parsons LL et al (2006) Conservation surgery for breast cancer as the preferred choice: a prospective analysis. J Clin Oncol 24(21):3367–3373CrossRefPubMed

25.

Murchie P, Norwood PF, Pietrucin-Materek M, Porteous T, Hannaford PC, Ryan M (2016) Determining cancer survivors’ preferences to inform new models of follow-up care. British J Cancer 115(12):1495–1503CrossRef

26.

Hugh-Yeun K, Kumar D, Moghaddamjou A, Ruan JY, Cheung WY (2017) Young adult cancer survivors’ follow-up care expectations of oncologists and primary care physicians. J Cancer Survivorship : Res Pract 11(3):295–301. https://doi.org/10.1007/s11764-016-0587-7 CrossRef

27.

Chubak J, Aiello Bowles EJ, Tuzzio L, Ludman E, Rutter CM, Reid RJ, Wagner EH (Jun 2014) Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv 8(2):229–238. https://doi.org/10.1007/s11764-013-0335-1 CrossRefPubMed

28.

Hudson SV, Miller SM, Hemler J, Ferrante JM, Lyle J, Oeffinger KC, DiPaola RS ’. Ann Fam Med Sep-Oct 2012;10(5):418–427, DOI: https://doi.org/10.1370/afm.1379 CrossRefPubMedPubMedCentral

29.

Hudson SV, Ohman-Strickland PA, Bator A, O’Malley D, Gundersen D, Lee HS, Crabtree BF, Miller SM (2016) Breast and prostate cancer survivors’ experiences of patient-centered cancer follow-up care from primary care physicians and oncologists. J Cancer Survivorship : Res Pract 10(5):906–914. https://doi.org/10.1007/s11764-016-0537-4 CrossRef

30.

Patton MQ (2002) Qualitative research & evaluation methods. Sage Publications, Thousand Oaks, CA

31.

Elo S, Kyngas H (Apr 2008) The qualitative content analysis process. J Adv Nurs 62(1):107–115. https://doi.org/10.1111/j.1365-2648.2007.04569.x CrossRefPubMed

32.

Hsieh HF, Shannon SE (Nov 2005) Three approaches to qualitative content analysis. Qual Health Res 15(9):1277–1288. https://doi.org/10.1177/1049732305276687 CrossRefPubMed

33.

Miles MB, Huberman AM (1994) An expanded sourcebook: qualitative data analysis, 2ne edn. SAGE Publications, Inc., Thousand Oaks, California

34.

Mao JJ, Bowman MA, Stricker CT et al (2009) Delivery of survivorship care by primary care physicians: the perspective of breast cancer patients. J Clin Oncol 27(6):933–938CrossRefPubMed

35.

Mayer EL, Gropper AB, Neville BA et al (2012) Breast cancer survivors’ perceptions of survivorship care options. J Clin Oncol 30(2):158–163CrossRefPubMed

36.

Wallner LP, Abrahamse P, Uppal JK et al (2016) Involvement of primary care physicians in the decision making and care of patients with breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol 34(33):3969–3975CrossRef

37.

Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC (2009) Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol: Off J Am Soc Clin Oncol 27(15):2489–2495CrossRef

38.

Oeffinger KC, Argenbright KE, Levitt GA, McCabe MS, Anderson PR, Berry E, Maher J, Merrill J, Wollins DS (2014) Models of cancer survivorship health care: moving forward. Am Soc Clin Oncol Educational book / ASCO American Society of Clinical Oncology Meeting 34:205–213. https://doi.org/10.14694/EdBook_AM.2014.34.205 CrossRef

39.

Oeffinger KC, McCabe MS Models for delivering survivorship care. J Clin Oncol: Off J Am Soc Clin Oncol, 2006 24(32):5117–5124CrossRefPubMed

40.

Watson EK, Sugden EM, Rose PW (Jun 2010) Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey. J Cancer Surviv 4(2):159–166. https://doi.org/10.1007/s11764-010-0117-y CrossRefPubMed

41.

Yang W, Williams JH, Hogan PF, Bruinooge SS, Rodriguez GI, Kosty MP, Bajorin DF, Hanley A, Muchow A, McMillan N, Goldstein M (Jan 2014) Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage. J Oncol Pract 10(1):39–45. https://doi.org/10.1200/JOP.2013.001319 CrossRefPubMed

Title: Breast cancer survivor’s perspectives on the role different providers play in follow-up care
Authors: J. L. Tucholka
N. Jacobson
N. M. Steffens
J. R. Schumacher
A. J. Tevaarwerk
B. Anderson
L. G. Wilke
C. C. Greenberg
Heather B. Neuman
Publication date: 01-06-2018
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 6/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-018-4042-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Importance

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2018

Humanistic burden of disease for patients with advanced melanoma in Canada

A national study of the unmet needs of support persons of haematological cancer survivors in rural and urban areas of Australia

Administrating docetaxel, doxorubicin, and cyclophosphamide as a neoadjuvant treatment may decrease lymphedema risk in breast cancer patients

A systematic review of the measurement properties of the Body Image Scale (BIS) in cancer patients

Predictors of analgesic efficacy of neurolytic celiac plexus block in patients with unresectable pancreatic cancer: the importance of timing

Potential curability and perception of received information in esophageal cancer patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer